investors.curis.com/...-4948-in-Monotherapy-R-R-AML-and-hrMDS
|
Zahlen für Q4/22
- cash equivalents and investments should enable it to maintain its planned operations into 2025
investors.curis.com/...es-Fourth-Quarter-2022-Business-Update
www.fiercebiotech.com/biotech/...hold-phase-12-leukemia-study
Zahlen für Q1/23
- cash runway into 2025
investors.curis.com/...des-First-Quarter-2023-Business-Update
Zahlen für Q2/23
investors.curis.com/...es-Second-Quarter-2023-Business-Update
1/20 RS
www.sec.gov/ix?doc=/Archives/edgar/data/.../cris-20230926.htm
Zahlen für Q3/23
- cash runway into 2025
investors.curis.com/...des-Third-Quarter-2023-Business-Update
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
75 | Curis 2020 zum Outperformer? | grips | DrZaubrlhrling | 19.12.23 16:25 |